Don’t miss this on-demand panel discussion! Hear from industry experts Dino Di Carlo (University of California), Nik Matthews (Imperial College London), Linda Orzolek (OMAPiX), and Kevin Taylor (Revvity) as they share insights on single-cell sequencing and discuss how they are addressing various challenges.

Single-cell sequencing is transforming disease research by revealing the intricate diversity across cell populations, uncovering crucial biomarkers and therapeutic targets often masked by bulk approaches. This technique has been particularly impactful in cancer research, where it has advanced our understanding of tumor biology, paving the way for more targeted and effective treatments and, ultimately, precision healthcare.

Despite technology advances, which have rapidly boosted the adoption of single-cell sequencing experiments by increasing the number of cells analyzed and reducing the cost and complexity, many laboratories still struggle to incorporate this technique into their routine investigations.

Key discussion areas include:

• How leading institutions are using single-cell sequencing studies in their research
• Addressing current challenges in single-cell sequencing
• The importance of multi-omics approaches
• How single cell sequencing is contributing to precision medicine

For research use only. Not for use in diagnostic procedures.